CXCL10 and neoplasm: This leads to type I interferon (IFN) production by cDC1 TIDCs and promotes their migration to the tumor-draining lymph node, thereby priming MSA-specific CD8+ T cells and promoting their migration to the tumor via CXCL10 (11).